Package 49884-873-72

{"route": ["ORAL"], "spl_id": "d7b2a60c-b7ac-4353-af15-8f0c5fafd172", "openfda": {"upc": ["0349884873721"], "unii": ["RG277LF5B3"], "rxcui": ["1653217"], "spl_set_id": ["2e13a3b5-e4df-4d5c-9b26-02a7006a7c3e"], "manufacturer_name": ["ENDO USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 PACKET in 1 CARTON (49884-873-72)  / 1 POWDER, FOR SOLUTION in 1 PACKET (49884-873-52)", "package_ndc": "49884-873-72", "marketing_start_date": "20201001"}], "brand_name": "SAPROPTERIN DIHYDROCHLORIDE", "product_id": "49884-873_d7b2a60c-b7ac-4353-af15-8f0c5fafd172", "dosage_form": "POWDER, FOR SOLUTION", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Phenylalanine Hydroxylase Activator [EPC]", "Phenylalanine Hydroxylase Activators [MoA]"], "product_ndc": "49884-873", "generic_name": "SAPROPTERIN DIHYDROCHLORIDE", "labeler_name": "ENDO USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "SAPROPTERIN DIHYDROCHLORIDE", "active_ingredients": [{"name": "SAPROPTERIN DIHYDROCHLORIDE", "strength": "500 mg/1"}], "application_number": "ANDA210027", "marketing_category": "ANDA", "marketing_start_date": "20201001", "listing_expiration_date": "20261231"}